Zusammenfassung
Über Faktor VIII- und Faktor IX-Substitution sind seit 1980, auch in Deutschland, eine zunächst steigende Zahl von Hämophilie-Patienten mit dem „human immunodeficiency virus“ HIV (früher LAV/HTLV-III) infiziert worden (Tab. 1) (1, 2, 3, 4, 5).
This is a preview of subscription content, log in via an institution.
Preview
Unable to display preview. Download preview PDF.
Literatur
Mathez, D., J. Leibovitch, Y. Sultan, P. Maisonneuve: LAV/HTLY III seroconversion and disease in hemophiliacs treated in France. New Engl. J. Med. 314, 118–119 (1986)
Gürtler, L.G., D. Wernicke, J. Eberle, G. Zoulek, F. Deinhardt, W. Schramm: Increase in prevalence of anti-HTLV III in hemophiliacs. Lancet II, 1275–1276 (1984)
Evatt, B.L., E.D. Gomperts, J.S. McDougal, R.B. Ramsey: Coincidental appearance of LAV/HTLV III antibodies in hemophiliacs and the onset of the AIDS epidemic New Engl. J. Med. 312, 483–486 (1985)
Machin, S.J., B.A. McVerry, R. Cheingsong-Popov, R.S. Tedder: Serokonversion for HTLV III since 1980 in British hemophiliacs. Lancet i, 336 (1985)
Ludlam, C.A., J. Tucker, C.M. Steel, R.S. Tedder, R. Cheingsong-Popov, R.A. Weiss, D.B.L. McClelland, I. Philip, R.J. Prescott: Human T-Lymphotropic virus Typ III (HTLV III) infection in seronegative hemophiliacs after transfusion of factor VIII. Lancet ii, 233–236 (1985)
White, G.C., T.J. Matthews, K.J. Weinhold, B.F. Haynes, H. Le Roy Cromartie, C.W. McMillan, D.P. Bolognesi: HTLV III seroconversion associated with heat-treated Factor VIII concentrate. Lancet i, 611–612 (1986)
van den Berg, W., J.W. ten Cate, C. Breederveld, J. Goudsmit: Seroconversion to HTLV III in a hemophiliac given heat-treated factor VIII concentrate. Lancet i, 803–804 (1986)
Mdsseler, J., Kl. Schimpf, G. Auerswald, H. Bayer, J. Schneider, G. Hunsmann: Inability of pasteurized factor VIII preparations to induce antibodies to HTLV III after long term treatment Lancet i, 1111 (1985)
Felding, P., I.M. Nilsson, B.G. Hansson, G. Biberfeld: Absence of antibodies to LAV/HTLV III in haemophiliacs treated with heat-treated factor VIII concentrate of American origin. Lancet ii, 832–833 (1985)
Rouzioux, C., S. Chamaret, L. Montagnier, V. Carnelli, G. Rolland, P. Mannuci: Absence of antibodies to AIDS virus in haemophiliacs treated with heat-treated factor VIII concentrate. Lancet i, 271–272 (1985)
Anonymous: Needlestick transmission of HTLV III from a patient infected in Africa Lancet ii, 1376–1377
Mayer, K.H., A.M. Stoddard, J. McCuster, D. Ayotte, R. Feriani, J. Groopman: Human T-lymphotropic virus type III in high risk, antibody negative homosexual men Ann. Int. Med. 104, 194–196 (1986)
Cavel, F., D. Guetard, F. Brun-Vezinet, S. Chamaret, M.A. Rey, M.O. Santos-Ferreira, A.G. Laurent, C. Dauguet, C. Katlama, C. Rouzioux, D. Klatzmann, J.L. Champalimaud, L. Montagnier: Isolation of a new human retrovirus from West African patients with AIDS Science 233, 343–346 (1986)
McDouga1, J.S., L.S. Martin, S.P. Cort, M. Mozert, C.M. Heldebandt, B.L. Evatt: Thermal inactivation of the Acquired Immunodeficiency Syndrome Virus, Human T-lymphotropic v irus-111/Lymphadenopathy-associ ated virus, with special reference to antihemophilic factor J. Clin. Invest. 76, 875–877 (1985)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Gürtler, L., Schramm, W., Weisser, J., Krauss-Dietz, B. (1987). Ungeklärte HIV Serokonversionen nach Substitution mit hitzeinaktivierten Faktorenkonzentraten. In: Landbeck, G., Schimpf, K. (eds) 3. Rundtischgespräch über aktuelle Probleme der Substitutionstherapie Hämophiler. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72825-9_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-72825-9_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-18059-3
Online ISBN: 978-3-642-72825-9
eBook Packages: Springer Book Archive